$0.3050
0.00712.38%
Last update: Nov 11, 10:18 AM
Mereo BioPharma Group PLC
MREONASDAQ
Mereo BioPharma fell 84.1% from $1.87 to $0.30, behind the S&P 500's +9.8%. Its worst day was Dec 29 (−87.6%), and its low came May 6 at $0.24.
Nov 11, 2025 – Nov 10, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Mereo BioPharma closed at its highest level of the year, 23.5% above where the year started.
+6.0% · S&P 500 +0.7%
Mereo BioPharma shares fell 87.6%, while the S&P 500 fell 0.4%.
Story events cover the past 12 months · Times ET
−87.6%, the year's worst day, on 241M shares, the year's heaviest volume · S&P 500 −0.4%
Mereo BioPharma shares rose 28.6%, while the S&P 500 rose 0.7%.
+28.6% · S&P 500 +0.7%
EPS of $-0.01 beat the $-0.01 estimate on $0.00 revenue (est. $5.3M).
+2.6% · S&P 500 −0.5%
EPS of $-0.01 missed the $0.02 estimate on $0.00 revenue (est. $10.5M).
+1.4% · S&P 500 −0.2%
EPS of $-0.01 beat the $-0.01 estimate on $0.00 revenue (est. $863,830.00).
+12.2% · S&P 500 −0.3%
EPS of $-0.01 beat the $-0.01 estimate on $800,000.00 revenue.
+5.3% · S&P 500 +2.4%
Where it ended: a close of $0.30 on Nov 10, 2026.
Nothing in the past 12 months.
All MREO dividend historyChart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for MREO and SPY from Benzinga historical bars. Not investment advice.
